Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Braveny

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Infection|January 1, 1979
[In vitro activity of cefaclor against Haemophilus influenzae in comparison to various oral chemotherapeutic agents (author's transl)]I Braveny
European Journal of Clinical Microbiology|October 1, 1984
In vitro activity of imipenem--a reviewI Braveny
Arzneimittel-Forschung|January 1, 1980
[In vitro activity of rosoxacin (Win 35 213) against Neisseria gonorrhoeae (author's transl)]I Braveny, K Machka
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 24, 2001
Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990sG Maschmeyer, I Braveny
Journal of Clinical Pathology|September 1, 1980
Enzyme-linked immunosorbent assay for the serodiagnosis of toxoplasmosisD Milatović, I Braveny
European Journal of Clinical Microbiology|August 1, 1983
In vitro activity of HR 810, a new broad-spectrum cephalosporinK Machka, I Braveny
European Journal of Clinical Microbiology|August 1, 1987
Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivativeK Machka, I Braveny
Immunitat Und Infektion|August 1, 1978
[Indirect hemagglutination test for detection of toxoplasma antibodies (author's transl)]C Fesefeldt, I Braveny
European Journal of Clinical Microbiology|February 1, 1987
Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocciK Machka, I Braveny
European Journal of Clinical Microbiology|June 1, 1987
Development of resistance during antibiotic therapyD Milatovic, I Braveny
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Infection|January 1, 1979
[In vitro activity of cefaclor against Haemophilus influenzae in comparison to various oral chemotherapeutic agents (author's transl)]I Braveny
European Journal of Clinical Microbiology|October 1, 1984
In vitro activity of imipenem--a reviewI Braveny
Arzneimittel-Forschung|January 1, 1980
[In vitro activity of rosoxacin (Win 35 213) against Neisseria gonorrhoeae (author's transl)]I Braveny, K Machka
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 24, 2001
Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990sG Maschmeyer, I Braveny
Journal of Clinical Pathology|September 1, 1980
Enzyme-linked immunosorbent assay for the serodiagnosis of toxoplasmosisD Milatović, I Braveny
European Journal of Clinical Microbiology|August 1, 1983
In vitro activity of HR 810, a new broad-spectrum cephalosporinK Machka, I Braveny
European Journal of Clinical Microbiology|August 1, 1987
Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivativeK Machka, I Braveny
Immunitat Und Infektion|August 1, 1978
[Indirect hemagglutination test for detection of toxoplasma antibodies (author's transl)]C Fesefeldt, I Braveny
European Journal of Clinical Microbiology|February 1, 1987
Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocciK Machka, I Braveny
European Journal of Clinical Microbiology|June 1, 1987
Development of resistance during antibiotic therapyD Milatovic, I Braveny
Pageof 5